NEWS Maryland Medical Cannabis

Twitter-Safer-than-selfies-128701.png
 
This is what the one up the road will be starting out with as far as stock. Flowers and concentrates might vary some over the flowers but we'll see. Im excited :)

Blue Dream
Blueberry Diesel
Bubba Kush
Cannatonic
MJardin CBD
Durban Poison
Knockout Kush
Golden Goat
Granddaddy Purps
Harlequin
Jack Flash
Grandpa Abe
Purple Pineapple Kush
Fruity Pebbles OG
Maui Wowie OG
CBD Therapy
Platinum Cookies
Sour Diesel
Maui Crush

These strains provide a varied mix of cannabinoid contents as well as species (indica, sativa, indica dominant hybrids, sativa dominant hybrids, and 50/50 hybrids). Specifically, Cannatonic, MJardin CBD, and Harlequin are higher in cannabidiol (CBD) content than most cannabis strains. Cannabidiol (CBD) is a promising nonpsychoactive constituent widely accepted in medical and non-medical communities for minimizing chronic pain, seizures, and epilepsy. CBD blocks and stabilizes excitatory receptors such as NMDA, the over-reactive receptors in most epileptic conditions. A potent anti-inflammatory, anti-spasmodic, and neuro-protective substance, CBD dramatically reduces anxiety without affecting mental processes. CBD is well known for providing relaxation without sedation and relief without intoxication. We will offer products based on the following high-CBD strains:

While we plan to offer a wide variety of strains with varying THC and CBD levels we cannot guarantee which strains these will be as we are dependent upon what strains are offered by Maryland Growers.
Cannatonic
with nearly a 1:1 ratio of THC to CBD (CBD up to 24% by weight), is not particularly psychoactive as a daytime analgesic and anti-inflammatory medicine. It contains significant amounts of cannabigerol (CBG), known to play roles in reducing inflammation, inhibiting cell growth in tumor/cancer cells, and promoting bone growth. Cannatonic also contains higher proportions of beta-myrcene, known to provide more sedative effects, than typical strains.
Harlequin
with a 2:5 ratio of THC to CBD (up to 16% CBD by weight), is not a psychoactive medicine and provides treatment for pain and anxiety. It contains lower amounts of CBG but higher amounts of cannabichromene (CBC), also known to be involved in pain and inflammation reduction.
In addition to our cannabis flower product offerings, we will offer our patients medical cannabis extracts, both in liquid (oil) and solid (crystalline, wax) forms, ideally processed using carbon dioxide extraction processes. The solvent capacity of carbon dioxide can be tuned to selectively extract specific cannabinoid contents over others, providing another mechanism for tuning the composition of the final medical product. The resulting cannabis extracts range from 30-75% cannabinoids by weight. This concentration can be increased by simple physical and mechanical purification methods. Utilizing a food-grade solvent , e.g. organic cane-sugar-derived 200 proof alcohol, in conjunction with carbon dioxide solvent-tuning methods can yield extract products reaching as high as 90% cannabinoids by weight.

The extracts generated from both THC-dominant and CBD-dominant strains of medical cannabis have been used in studies (http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php) demonstrating their impact on and treatment of pain and inflammation reduction, multiple sclerosis, seizures, cancer, epilepsy, HIV, nausea, and glaucoma, among others.

We will continue to monitor research associated with chemical compositions and their effects on medical conditions to best identify products that address our patients’ medical conditions.
 
Currently, more than 60 U.S. and international health organizations — including the American Public Health Association, Health Canada and the Federation of American Scientists — support granting patients immediate legal access to medicinal marijuana under a physician’s supervision. Several others, including the American Cancer Society and the American Medical Association support the facilitation of wide-scale, clinical research trials so that physicians may better assess cannabis’ medical potential.

In addition, a 1991 Harvard study found that 44 percent of oncologists had previously advised marijuana therapy to their patients. Fifty percent responded they would do so if marijuana was legal. A more recent national survey performed by researchers at Providence Rhode Island Hospital found that nearly half of physicians with opinions supported legalizing medical marijuana.

Cannabis and its psychoactive cannabinoid, THC, are considered incredibly safe for human consumption. The Drug Awareness Warning Network Annual Report, published by the Substance Abuse and Mental Health Services Administration (SAMHSA), contains a statistical compilation of all drug deaths which occur in the United States. According to this report, there has never been a death recorded from the use of cannabis. In fact, many studies show it is physically impossible for a human to die from a cannabis overdose.


The documented use of cannabis as a safe and effective therapeutic botanical dates to 2700 BC. Between 1840 and 1900, European and American journals of medicine published more than 100 articles on the therapeutic use of cannabis. In fact, cannabis was part of the American pharmacopoeia until 1942, and is currently available by prescription in Canada, the Netherlands, Israel, and Germany.

The cannabis plant has been around for centuries. It is believed to have originated in Central Asia, but has expanded its reach to an international scale over time. People all around the globe consume cannabis and their reasoning is largely the same: it makes them feel better.

We know that humans have cannabinoid receptors housed inside the body that are ready to bind with cannabinoids found in the cannabis plant to provide therapeutic benefits for a variety of ailments. In fact, cannabinoid receptors are present in humans before birth and the compounds themselves are even found in a mother’s breast milk. Medical cannabis gains merit when you consider our bodies are naturally tuned to interact with cannabinoids, and even more so when you acknowledge the growing evidence of benefits to cannabis consumption.
 
Cannabis & Digestion
It is no secret – experiencing “the munchies” is one of the most obvious cannabis clichés. Despite the silly connotation, studies suggest that the endocannabinoid system actually helps modulate appetite. This is especially interesting for the treatment of eating disorders. In fact, a study published in the International Journal of Eating Disorders suggests that cannabinoids may prove effective in treating anorexia.

Cannabis is also famously used to reduce the feelings of nausea but studies suggest it could have a number of digestive benefits as well. Medical marijuana could play a role in a number of digestion-related health conditions including:
• Crohn’s Disease and Cannabis
• Obesity and Cannabis
• Diabetes and Cannabis
Medical Cannabis For Pain Management
Chronic Pain is one of the most common ailments for which doctors prescribe medical cannabis and a recent survey published in The Spine Journal found that 1 out of 5 patients at a Colorado spine center were using cannabis to manage their pain. Of those, nearly 90% said it greatly or moderately relieved their pain.

The spine clinic study was merely a survey, which means more research will be necessary on the potential role of cannabis in treating back pain. With that said, plenty of people will tell you it helps manage pain and science is beginning to back their claims. Studies suggest medical marijuana could offer relief for various types of pain, including the following:
• Chronic Pain and Cannabis
• Neuropathic Pain and Cannabis
Medical Cannabis For Cancer
One the most intriguing potential applications for medical cannabis is cancer treatment. It has long been prescribed to counter the side effects of chemotherapy, but oncologists across the world are working on trials to determine whether cannabis can be used to treat cancer itself. Many patients choose to take the Rick Simpson Oil treatment plan in an attempt to cure the cancer, but there are many different methods of going about treatment.

Past research showed promise for THC in cancer treatment, but many are skeptical of using THC-based products because of its psychotropic effects (eg. the “high”). As a result many oncologists have redirected their focus toward cannabidiol (CBD) and cannabigerol (CBG). A recent British study, however suggests that cannabinoids may be most effective against cancer when combined in a manner that allows them to act synergistically with one-another. Below is a short list of studies and research supporting cancer treatment with medical cannabis to get you started:
• Breast Cancer and Cannabis
• Brain Cancer and Cannabis
• Lung Cancer and Cannabis
• Skin Cancer and Cannabis
• Tumor Growth and Cannabis

Cannabis & Mental Health
A common misconception of cannabis is that has detrimental effects on mental health. It is possible that high doses of tetrahydrocannabinol (THC) could trigger anxiety in some patients, and some believe it could expedite the onset of predisposed personality disorders, but this has yet to be proven by any reputable studies.

The recent trend in the mental health field has been to investigate our relationship with cannabis. In turn, studies have linked cannabinoids to a number of mental health concerns. The research catalog is still growing, but a few mental health conditions for which cannabis could be beneficial are as follows:
• Alcoholism and Cannabis
• Opiate Withdrawal and Cannabis
• Depression and Cannabis
• Phobias and Cannabis
• Schizophrenia and Cannabis
Your Brain On Cannabis
Not only has cannabis been linked to mental health, cannabinoid receptor activity in the brain before birth suggests that the compounds could be play a role in brain development. Cannabis has been linked to the creation of new neurons in the brain, or neurogenesis, and overall brain plasticity. In addition to its role in brain development, medical cannabis is believed to have neuroprotective properties that help treat the following conditions:
• Alzheimer’s Disease and Cannabis
• Parkinson’s Disease and Cannabis
• Oxygen Deficits and Cannabis
 
cool thing is you can sidestep your Primary doc too. if you have it documented in your records ,you go right to the source and get a card. and the other kewl thing is that MMCC will decide on a case by case basis IF your dont have one of the conditions listed. so its open kinda right now.but Doctors and PA's,even dentists can give a simple Recommendation ,but its not needed. but most are taught to avoid talking about it even though most do know its mostly a benign medicine in that it doesnt react with most anything they do ,give or treat ppl with for whatever reason. usually enhances it.
 
Back
Top